medigraphic.com
ISSN 0187-5337 (Print)
Instituto Nacional de Perinatología

2012, Number 3

<< Back Next >>

Perinatol Reprod Hum 2012; 26 (3)

Addicted mothers: determination of drug levels and evaluation of growth and development of their children in the first six months of life

Arroyo-Cabrales LM, Canseco-Herrera M, Castillo-Romero MG, Belmont-Gómez A

Language: Spanish
References: 17
Page: 180-186
PDF size: 109.64 Kb.


ABSTRACT

Objective: Know the levels of marihuana, cocaine, benzodiazepines and morphine in maternal blood, umbilical cord and breast milk, in a group of addicted mothers of the Instituto Nacional de Perinatología from August 1st 2006 to July 31th 2008; and evaluate growth and development of their offspring monthly during the first six months of life. Material and methods: We performed an observational, longitudinal and prospective study, including mother-infant binomio with drug addiction during pregnancy or exposed one year before, or if their sexual partners were addicted too. For determining drug levels, samples from maternal blood, umbilical cord and breast milk, were taken and processed by enzyme immunoassay technique. Growth of infants during the first six months of life, and the neurological development were done. The data was analyzed with descriptive statistics. Results: The study included 54 patients; maternal age between 19-29 years in 57.4% of the cases. Two or more drugs were consumed in 38.9% of the cases and marihuana and cocaine, were the most used combination, no abstinence syndrome documented. Cocaine levels were positive in four (7%) patients; marihuana in 21 patients (38.9%); opioids in 14 (26%) patients; amphetamines in one (1.9%) patient and benzodiazepine in 18 (33.3%) cases. In the six months of follow up, there were no alterations on growth and the neurological development was normal in 85.2% of the cases. Discussion: In our society the addiction to recreative drugs is a public health problems. A close follow up of growth and neurological development is mandatory in these children and determining drug levels samples in breast milk, are necessary to achieve this goal.


REFERENCES

  1. Evans AT, Gillogley K. Uso de sustancias ilícitas durante el embarazo; perspectivas obstétricas. Clin Perinatol 1991; 1: 25-35.

  2. Vega WA, Kolody B, Hwang J, Noble A. Prevalence and magnitude of perinatal substance exposure in California. N Eng J Med 1993; 329: 850-4.

  3. Neonatal drug withdrawal. American Academy of Pediatrics Committee on Drugs. Pediatrics 1998; 101: 1079-88.

  4. García-del-Río M, Lastra-Sánchez G, Medina-Soto A, Martínez-León M, Lucena-Travé J, Martínez-Velarde A. Enfoque diagnóstico-terapéutico del hijo de madre drogadicta. En: Protocolos diagnósticos y terapéuticos en pediatría. Asociación Española de Pediatría 2002: 119-25.

  5. Abdel-Latif ME, Pinner J, Clews S, Cooke F, Lui K, Oei J. Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers. Pediatrics 2006; 117: e1163-9.

  6. Amiel TC et al. Valoración neurológica del recién nacido y del lactante. Barcelona: Toray-Masson, S.A.; 1981: 1-49.

  7. Aguilera CA, Siria RC, Hernández GA, Loredo AA. Morbilidad neonatal por drogadicción de la mujer embarazada. Acta Pediatr Mex 2005; 26: 244-9.

  8. Hepburn M. Substance abuse in pregnancy. Curr Obstet Gynaecol 2004; 14: 419-25.

  9. Aguilera C, Aguirre I. Abuso de sustancias tóxicas durante el embarazo. Med Clin (Barc) 2005; 125: 714-6.

  10. Uberos FJ. Hijo de madre adicta a drogas. Bol SPA On 2010; 4: 190-8.

  11. Shanti CM, Lucas CE. Cocaine and the critical care challenge. Crit Care Med 2003; 31: 1851-9.

  12. Ness RB, Grisso JA, Hirschinger N, Markovic N, Shaw LM, Day NL et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med 1999; 340: 333-9.

  13. Butz AM, Pulsifer M, Marano N, Belcher H, Lears MK, Royall R. Effectiveness of a home intervention for perceived child behavioral problems and parenting stress in children with in utero drug exposure. Arch Pediatr Adolesc Med 2001; 155: 1029-37.

  14. González-Hachero J, Martínez Malagón MC. Repercusiones en los hijos de la drogadicción de los padres. An Esp Pediatr 1999; 51: 4-8.

  15. Delaney-Black V, Covington C, Nordstrom B, Ager J, Janisse J, Hanigann JH et al. Prenatal cocaine: quantity of exposure and gender moderation. J Dev Behav Pediatr 2004; 25: 254-63.

  16. Finnegan LP. Neonatal abstinence. In: Nelson NM, editor. Current therapy in neonatal-perinatal medicine. Toronto: Decker; 1985: 262-70.

  17. Bolnick JM, Rayburn WF. Substance use disorders in women: special considerations during pregnancy. Obstet Gynecol Clin North Am 2003; 30: 545-58.




2020     |     www.medigraphic.com